• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease.

作者信息

Beyersdorf Friedhelm, Vahanian Alec, Milojevic Milan, Praz Fabien, Baldus Stephan, Bauersachs Johann, Capodanno Davide, Conradi Lenard, De Bonis Michele, De Paulis Ruggero, Delgado Victoria, Freemantle Nick, Gilard Martine, Haugaa Kristina H, Jeppsson Anders, Jüni Peter, Pierard Luc, Prendergast Bernard D, Sádaba J Rafael, Tribouilloy Christophe, Wojakowski Wojtek

出版信息

Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac209.

DOI:10.1093/ejcts/ezac209
PMID:35352803
Abstract
摘要

相似文献

1
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease.《2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南》勘误
Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac209.
2
Corrigendum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).勘误：《2021 ESC/EACTS 心脏瓣膜病管理指南》：由欧洲心脏病学会（ESC）心脏瓣膜病管理特别工作组和欧洲心胸外科学会（EACTS）制定。
Eur Heart J. 2022 Jun 1;43(21):2022. doi: 10.1093/eurheartj/ehac051.
3
Corrigendum to: 2017 ESC/EACTS Guidelines for the management of valvular heart disease.《2017年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南》勘误
Eur Heart J. 2018 Jun 1;39(21):1980. doi: 10.1093/eurheartj/ehx636.
4
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].《2017年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南》勘误[《欧洲心胸外科杂志》2017年；52:616 - 664]
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):832. doi: 10.1093/ejcts/ezx363.
5
Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.勘误：《2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南》：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC的欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Oct 21;42(40):4194. doi: 10.1093/eurheartj/ehab648.
6
Erratum to: 2021 ESC/EACTS Guidelines for the management of valvular heart disease.《2021 ESC/EACTS 心脏瓣膜病管理指南》勘误
Eur J Cardiothorac Surg. 2022 Mar 24;61(4):964. doi: 10.1093/ejcts/ezab557.
7
2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.2017年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南
Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):110. doi: 10.1016/j.rec.2017.12.013.
8
ESC/EACTS Guidelines on the management of valvular heart disease.欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南
Eur Heart J. 2012 Oct;33(19):2371-2. doi: 10.1093/eurheartj/ehs273.
9
Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease.对2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南的评论
Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):466-471. doi: 10.1016/j.rec.2021.11.024. Epub 2022 Apr 12.
10
[ESC/EACTS Guidelines for the management of valvular heart disease: what's new from the cardiac surgeon's perspective].[欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南：从心脏外科医生角度看有哪些新内容]
G Ital Cardiol (Rome). 2022 Mar;23(3):165-168. doi: 10.1714/3751.37333.

引用本文的文献

1
Study protocol for an internahaational prospective non-randomised trial evaluating the long-term outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement for aortic-valve stenosis in patients at risk to severe valve obstruction: the TAVISAR trial.一项国际前瞻性非随机试验的研究方案，该试验旨在评估经导管主动脉瓣植入术与外科主动脉瓣置换术治疗有严重瓣膜狭窄风险的主动脉瓣狭窄患者的长期疗效：TAVISAR试验
BMJ Open. 2025 May 24;15(5):e101417. doi: 10.1136/bmjopen-2025-101417.
2
Transapical vs. Transaxillary Access in Transcatheter Aortic Valve Implantation: Comparative Mortality and Long-Term Outcomes Using Inverse Probability of Treatment Weighting Analysis.经心尖与经腋动脉入路在经导管主动脉瓣植入术中的应用：使用治疗权重反概率分析的比较死亡率和长期结局
J Clin Med. 2025 Mar 25;14(7):2235. doi: 10.3390/jcm14072235.
3
AI-Enhanced Prediction of Aortic Stenosis Progression: Insights From the PROGRESSA Study.人工智能增强的主动脉瓣狭窄进展预测：来自PROGRESSA研究的见解
JACC Adv. 2024 Sep 11;3(10):101234. doi: 10.1016/j.jacadv.2024.101234. eCollection 2024 Oct.
4
Clinical Utility of Three-Dimensional Echocardiography in the Evaluation of Mitral Valve Disease: Tips and Tricks.三维超声心动图在二尖瓣疾病评估中的临床应用：技巧与窍门
J Clin Med. 2023 Mar 27;12(7):2522. doi: 10.3390/jcm12072522.
5
Myocardial Perfusion and Coronary Physiology Assessment of Microvascular Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation-Rationale and Design.经导管主动脉瓣植入术患者微血管功能障碍的心肌灌注与冠状动脉生理学评估——原理与设计
Biomimetics (Basel). 2022 Dec 8;7(4):230. doi: 10.3390/biomimetics7040230.
6
Non-Inferiority of Sutureless Aortic Valve Replacement in the TAVR Era: David versus Goliath.经导管主动脉瓣置换术（TAVR）时代无缝合主动脉瓣置换术的非劣效性：大卫对阵歌利亚
Life (Basel). 2022 Jun 29;12(7):979. doi: 10.3390/life12070979.
7
Transcatheter Aortic Valve Implantation: A Report on Serbia's First Systematic Program.经导管主动脉瓣植入术：塞尔维亚首个系统性项目报告。
Front Cardiovasc Med. 2022 May 24;9:882854. doi: 10.3389/fcvm.2022.882854. eCollection 2022.